International Journal of Health Sciences and Research ISSN:

Similar documents
Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

International Journal of Health Sciences and Research ISSN:

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)

Study of Cervical Pap Smears in a Tertiary Hospital

Understanding Your Pap Test Results

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

Cervical Cancer : Pap smear

Cervical Precancer: Evaluation and Management

BC Cancer Cervix Screening 2015 Program Results. February 2018

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

Lesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years

International Journal of Biological & Medical Research

Pap Smear and Histopathological Study of Cervical Lesions

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

International Journal of Health Sciences and Research ISSN:

STUDY OF EARLY DETECTION OF CERVICAL CANCER BY PAP S SMEAR IN SELECTED SETTING OF PUDUCHERRY

Chapter 10: Pap Test Results

Shrestha P CORRESPONDENCE

Role of cytology, colposcopy and colposcopic directed biopsy in the evaluation of unhealthy cervix

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Should Anal Pap Smears Be a Standard of Care in HIV Management?

Making Sense of Cervical Cancer Screening

A Study on Cervical Pap Smear Examination in Patient Living with HIV.

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

AgNOR Count and its Correlation with Colposcopy in Suspicious Cervix

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

The ABCs of TBS. A Novice's Guide to the Bethesda System

International Journal of Health Sciences and Research ISSN:

JMSCR Vol 05 Issue 03 Page March 2017

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

What is a Pap smear?

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Histopathological Correlation with Cervical Cytology

Done by khozama jehad. Neoplasia of the cervix

JMSCR Vol 07 Issue 02 Page February 2019

JMSCR Vol 05 Issue 11 Page November 2017

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

Epidemiologic Study of Colposcopy in Clinical Centers of Kermanshah, Iran, during 2006 to 2011

Effectiveness of opportunistic screening for cancer of the cervix uteri

Comparative Study of Pap Smear and Cervical Biopsy Findings

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

Colposcopy. Attila L Major, MD, PhD

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Use of Schiller s test versus Pap smear to increase detection rate of cervical dysplasias

A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube

Your Colposcopy Visit

Fluorescence Spectroscopy: A New Approach in Cervical Cancer

Profile Of Cervical Smears Cytology In Western Region Of Saudi Arabia

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

International Journal of Health Sciences and Research ISSN:

HPV AND CERVICAL CANCER

SCREENING FOR CERVICAL CANCER BY PAP SMEAR

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Clinical Practice Guidelines June 2013

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

The society for lower genital tract disorders since 1964.

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Detection Of Abnormal Cervical Cytology In Papanicolaou Smears At A Tertiary Care Hospital

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy

Uterine Cervical Smear Patterns In Females Attending A Teaching Hospital In Rural Eastern Uttar Pradesh, INDIA.

TISSUE TUMOR MARKER EXPRESSION IN

PREVENTION OF CERVICAL CANCER

Study of PAP smear examination in patients complaining of leucorrhoea - A 2 years prospective study in a teaching hospital

Cervical Dysplasia and HPV

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

Cytology and Surgical Pathology of Gynecologic Neoplasms

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

Comparison between Pap smear and visual inspection with acetic acid in screening of premalignant cervical intraepithelial lesion and

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Pattern of Pap smear Cytology and Its Histopathological Correlation at a Tertiary Care Center

Human Papillomavirus

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

Eradicating Mortality from Cervical Cancer

Cytological Screening for early Diagnosis of Cervical Intraepithelial Neoplasia (CIN) and early Carcinoma of Cervix.

HPV the silent killer, Prevention and diagnosis

Knowledge of Carcinoma Cervix among rural women of Reproductive age in Trichy district, India

Estimated New Cancers Cases 2003

Mojgan Karimi-Zarchi, Fateme Peighmbari, Neda Karimi, Mitra Rohi, Zohre Chiti. Shahid Sadoughi University of Medical Science, Yazd, Iran

PREVALENCE, ASSOCIATED RISK FACTORS AND METHODS OF DIAGNOSING CERVICAL CANCER IN TWO HOSPITALS IN YAOUNDE, CAMEROON

UTILITY OF PAP SMEAR STUDY IN THE DIAGNOSIS OF VARIOUS NONN NEOPLASTIC LESIONS OF CERVIX.

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

I have no financial interests to disclose.

Cellular Pathology Of Glandular Lesions And Uncommon Neoplasms Of The Cervix By Glenn McCluggage;John Tidy;John Smith READ ONLINE

Screening for cervical cancer and precancerous lesions in Tabriz

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

Diagnostic Value of VIA Comparing with Conventional Pap Smear in the Detection of Colposcopic Biopsy Proved CIN

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

Article ID: WMC

Transcription:

International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Retrospective Analysis of 1000 Cases of Cervical Pap Smears Sabina Shrestha 1, Kricha Pande 2 1 Consultant Pathologist, Department of Pathology, Norvic International Hospital 2 Lecturer, Department of Pathology, Nepal Medical College and Teaching Hospital. Corresponding Author: Sabina Shrestha Received: 23/12/2016 Revised: 09/01/2017 Accepted: 17/01/2017 ABSTRACT Introduction: Carcinoma of the cervix is the most common cancer of women in developing countries including Nepal. The Pap smear screening is an effective method for identifying intra epithelial lesions of cervix. Aims and Objectives: To determine the type and prevalence of abnormal cervical epithelial lesions in patients presenting with abnormal uterine bleeding at Patan Hospital. Materials and Methods: This is a retrospective study of all the cervical pap smear cases reported to the Department of pathology at Patan Hospital. The duration of study was dated from 1 st May 2012 to 30 th April 2014 and total 1,000 cases were enrolled for the study. Results: Most of the patients were in between 41-50 years (30%) followed by 51-60 years (28%) in age. Predominance of inflammatory smears was noticed in 894 (89.4%) cases. In this study, there were 106 (10.6%) cases of abnormal epithelial lesions out of which 27cases i.e. 2.7% were diagnosed as Atypical squamous epithelial cells of undetermined significance (ASCUS), 43(4.3%) cases were diagnosed as Low grade SIL and 29(2.9%) cases were found to be high grade SIL on Pap smear. In the present study, 7 cases (0.70%) were diagnosed as squamous cell carcinoma which is found to be maximum between 51-70 years of age. The commonest risk factors for squamous cell carcinoma in this study are early marriage, before the age of 20 years and low socioeconomic status. Conclusion: This study concludes that cervical Pap smear test is very helpful in early diagnosis of cervical cancer and it s precursor lesions.it is a simple, safe, inexpensive and painless method for diagnosis of the precancerous lesions and carcinoma of cervix. Key words: Pap smear, Intra epithelial lesion, Cervical Carcinoma, INTRODUCTION Carcinoma of the cervix is the most common cancer of women in developing [1] countries. Each year approximately 4,65,000 new cases of invasive cancer of the cervix are diagnosed and the mortality due to carcinoma of the cervix worldwide is around 2,00,000 per year. [2] Cervical carcinoma is more common in developing countries than in developed ones, particularly in parts of Asia, South [3] America and Africa. Around 3,200 women are diagnosed with cervical cancer in UK each year. [5] Carcinoma of cervix is the fourth commonest cancer in Singapore, making up 7.2% of all female cancers diagnosed between 1993 and 1997. [4] In India, the annual incidence of carcinoma of cervix is estimated to be 5,00,000 new cases per year. Carcinoma of cervix accounts for 25-50% of total cancers while for 86-90% of all genital cancers in Indian women. [5] In Nepal gynecological malignancy, particularly the cervical cancer is the most prevalent cancer. [6] International Journal of Health Sciences & Research (www.ijhsr.org) 103

Cervical carcinoma does not develop directly from normal epithelium but is preceded by a spectrum of intra epithelial neoplastic changes. [7] Upto one third of untreated, pre-cancerous lesion could develop into carcinoma in about 10 to 15 [8] years. The Bethesda system, first introduced in 1989 is currently being followed worldwide to classify these lesions. [9] The Pap smear screening is an effective and useful screening tool for identifying pre-cancerous intra -epithelial lesions, which are often been treated on an outpatient basis. [10] The objective of this study was to determine the type and prevalence of abnormal cervical epithelial lesions in patients presenting with abnormal uterine bleeding at Patan Hospital which caters largely to women of low socioeconomic status. MATERIALS AND METHODS This is a retrospective study of all the cervical Pap smear cases reported to the Pathology department of Patan Hospital from 1 st May 2012 to 30 th April 2014. Total 1000 cases were included in this study. A detail history and clinical findings of the patients were noted from the requisition form. All of the cervical smear findings were noted and classified according to The 2001 Bethesda System reporting Pap smear cytology. Statistical Analysis The data were analyzed using Microsoft Excel 2003 for windows. OBSERVATIONS AND RESULTS Table I: Age distribution of patient Age(years) No. of patient Percentage <20yrs 0 0% 21-30yrs 271 27.1% 31-40yrs 392 39.2% 41-50yrs 205 20.5% 51-60yrs 101 10.1% 61-70yrs 31 3.1% Total 1000 100% Table 1: All the female patients were in the age group of 21-70 years. Most of the patients are in between 41-50 years (30%) of age followed by 51-60 years (28%). Table 1 demonstrates age distribution of all the patients. Table II: Table showing the frequency distribution of symptom complexes Symptoms No. of cases Percentage Lower abdominal pain 763 76.3% Abnormal vaginal bleeding 352 35.2% Whitish per vaginal discharge 391 39.1% Bleeding on coitus 227 22.7% Weight loss 142 14.2% Dysuria 81 8.1% Anorexia 37 3.7% Table2:The predominant complaints in all cases were lower abdominal pain 763 cases (76.3%) followed by abnormal vaginal bleeding in 352 cases (35.2%) and whitish discharge per vagina 391 cases (39.1%). Other symptoms were intercoital bleeding, dysuria, weight loss and anorexia. Table III: Cervical smear (Pap smear) findings in 1,000 cases Diagnosis No. of cases Percentage NIL 894 89.4% ASCUS 27 2.7% LSIL 43 4.3% HSIL 29 2.9% SCC 07 0.7% Total 1000 100% Table IV: Age distribution pattern in different types of lesion Age (years) Inflammatory smears (IL) ASCUS LSIL HSIL SCC Total 21-30 242 01 06 02-251 31-40 396 07 11 03-417 41-50 179 07 15 09 01 2 11 51-60 57 09 09 11 02 88 61-70 23 03 02 04 04 36 Total 897 27 43 29 07 1000 Percentage 89.7% 2.7% 4.3% 2.9% 0.7% 100% International Journal of Health Sciences & Research (www.ijhsr.org) 104

Table III depicts the different patterns of Pap smear findings. Predominance of inflammatory smears was noticed in 89.4 (89.4%) cases. Abnormal findings were noted in 106 (10.6%) cases. Out of 106 abnormal findings, the prevalence of low grade SIL was 4.3% followed by high grade SIL 2.9% with ASCUS 2.7% and squamous cell carcinoma of cervix 0.7%. Table IV shows the age distribution of the patients in relation to different types of Pap smear findings. This data shows that inflammatory smear was commonest finding in females of age group of 31-40 years. ASCUS was commonest in the age group 51-60 years. Similarly, squamous intraepithelial lesions (SIL) are more common in 31-60 years and peak incidence of both LSIL and HSIL is 41-50 and 51-60 years age group. Squamous cell carcinoma was found to be maximum between 61-70 years of age. Among 7 diagnosed of carcinoma, all women were in peri and postmenopausal age group. Table V: Relation of Inflammatory smears (IS), ASCUS, LSIL, HSIL, SCC with age at marriage. Type of Age at marriage < 20 Age at marriage > 20 lesion yrs yrs IS 278 (27.8%) 616 (61.6%) ASCUS 11 (1.1%) 16(1.6%) LSIL 13 (1.3%) 30(3.0%) HSIL 18 (1.8%) 11(1.1%) SCC 05 (0.5%) 02(0.2%) Total 325 (32.5%) 675(67.5%) In this present study, 7 cases were diagnosed as squamous cell carcinoma in Pap smear and we found out that 5 patient were married before 20 years of age. Similarly all the 7 cases of SCC were from poor socioeconomic status. However, among 894 cases of inflammatory smears, only 278 (31.09%) cases were married before the age of 20 years. DISCUSSION Carcinoma of cervix is the most common malignant tumor of female genital tract in most countries. On a global scale, cancer of cervix is one of the major causes of death, especially in third world countries, where such screening is often not routinely performed. Invasive cancer of the uterine cervix is preventable when its precursor lesions are detected and treated early. Cervical cytology has been in use now for more than 50 years, and has proven itself to be the main weapon of defence against this disease. As prevention is always better than cure, in Nepal s context also Pap smear screening should be designed to detect the precursor lesions in cervical epithelium which may antedate the development of invasive cancer by several years. A total 1000 patients were included in this study from 1 st May 2012 to 30 th April 2014. Predominance of inflammatory smears was noticed in 894 (89.4%) cases. Cronje et al (2001) reported similar preponderance of inflammatory smears in their study. [11] In another study conducted by Sharma S. (2000) higher frequency of inflammatory smears of 302 cases (45.3) was noted out of 667 cases. [12] In this study, there were 106(10.6%) cases of abnormal epithelial lesions. The percentage of epithelial abnormalities is 2.3%to 6.6% in USA, from 1.6% to 7.9% in the Middle East and 1.87% to 5.9% in India. [13] In this study 43(4.3%) cases were diagnosed as Low grade SIL and 29 (2.9%) cases were found to be high grade SIL on Pap smear. Shrivastav et al (1998) reported the incidence of low grade SIL to be 15% in 100 cases of Pap smear. [14] The HSIL was reported as high as 3.75 % in Zimbabwe. [15] In the present study, 7 cases (0.7%) were diagnosed as squamous cell carcinoma in Pap smear. Other types of malignancy (adenocarcinoma or sarcomas) were not detected. In a similar study done by Alasio et al (2000), 8 cases (2.87%) out of 278 cases were diagnosed as squamous cell carcinoma on Pap smears. [16] Mostafa et al (2000) reported the incidence of squamous cell carcinoma to be 5.93 %. [17] On correlation with age with inflammatory smears and Atypical Squamous cell of Undetermined Significance (ASCUS), the maximum International Journal of Health Sciences & Research (www.ijhsr.org) 105

numbers of inflammatory smear were presented between the age group of 31-60 years. Similar, correlation with age in inflammatory smears have found in other studies. Among 27 cases of ASCUS of our study 23 cases presented between the age group 31-60 years. However, Bogaertt et al (2001) in their study of 22,160 cases showed the age group with maximum number of cases to be in between 21-30 years. [18] In this study SIL is more common in 31-60 years and peak incidence of both LSIL and HSIL is 41-50 years. In a similar study done by Bogaertt et al (2001) the common age group of SIL 21-30 years and the peak incidence of HSIL occurred between the ages of 31-40 years. [18] Misra et al found that 51.5% of SIL cases were in above 40 years of age. [19] On correlation of age with Squamous cell carcinoma, age group for cervical cancer in this study is comparable to that reported in literature and is found to be maximum between 51-70 years of age. Among 7 diagnosed cases 6 women were postmenopausal. All of them had never been screened by the Pap smear test before. Patten et al (1996) studied the common age group for carcinoma cervix and it was found to be 53.4 years. [20] Similarly, Reagin and Hick et al (1953) in their study found the common age of carcinoma cervix to be 48years. [21] Bogaertt et al (2001) reported the common age group of squamous cell carcinoma as the 6 th decades. [18] Kobilkova et al (2001) studied that the incidence of cervical cancer had two peaks, one at age group of 40-49 years and another at age group of 55-65 years. [22] The commonest risk factors for Squamous cell carcinoma in this study are early marriage (before the age of 20 years) and low socioeconomic status. In this study out of 7 cases of SCC 5 patient were married before 20 years of age. However among 894 cases of IS only 278(31.09%) cases were married before the age of 20 years and 616 (68.90%) cases were married after the age of 20 years. Similarly all the 7 cases of SCC were from poor socioeconomic status. Ryan et al considered early marriage as the primi cause. [23] Similarly, in a study done by Ia Vecchia et al (1986) and Herrero R. et al (1989) the single most important risk factor is early age at first intercourse. [24,25] One explanation is that spermatozoa are considered to act as carcinogen to the cervical epithelium. It attacks the immature metaplastic cells in the transforming zone (TZ) causing these cells to transform into cervical intraepithelial neoplasm (CIN). Thus, the longer duration of marriage, the greater is the risk of exposure to spermatozoa and hence higher risk of carcinoma cervix. The most common clinical presentation in all cases were lower abdominal pain 763(76.3%) followed by abnormal vaginal bleeding 352(35.2%) and whitish discharge per vagina 391(39.1%). Moghal in his study observed menorrhagia (41%) as the most common symptoms. [26] In this study all the 7 cases of SCC never had cervical screening before. It is appropriate to continue to perform annual Pap tests in women considered to be at high risk for cervical cancer on the basis of the risk factors. Cervical smear can detect the presence of a premalignant lesion allowing for the prevention of cancer. Most of the time, patients present in advanced stage of the disease when treatment is less effective.the widespread use of Pap smear in developed countries has proven that if measures are taken for early detection of these types of cancer mortality and morbidity can be significantly minimized. In Iceland, 100% of the eligible population is screened every 2-3 years and the incidence of carcinoma of the cervix in 1980 had fallen to less than one third of that in 1965. [27] In Denmark, about 40% of the population is screened every 3-5 years and the incidence of carcinoma of the cervix over the 15 years of period fell by about two thirds. [28] It is appropriate to continue to perform annual Pap tests in women considered to be at high risk for cervical International Journal of Health Sciences & Research (www.ijhsr.org) 106

cancer on the basis of the risk. A large scale study encompassing women from different strata and age groups is required to determine the actual incidence of abnormal cervical epithelium lesions in Nepal. Cancer of Cervix should get priority in terms of control programs through mass screening in Nepal. CONCLUSION Carcinoma of the cervix is the most common cancer of women in developing countries including in Nepal. The Bethesda system classifies these lesions as squamous intraepithelial lesions (SIL). These precancerous lesions, if untreated would lead to the development of cervical carcinoma in a period of about 10-15 years. From this present study, it is concluded that cervical smear test is very helpful in early diagnosis of cervical cancer and its precursor lesions.it is a simple, safe, inexpensive and painless method for diagnosis of the precancerous lesions and carcinoma of cervix. So, it is very appropriate in a country like ours to continue regular PAP tests in women consider being at high risk for cervical cancer. ACKNOWLEDGEMENT We would like to thank all team and colleagues of Department of Pathology and Department of gynecology at Patan hospital for their invaluable help. REFERENCES 1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. 1998, CA 1998:48:6-29. 2. Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J cancer 1993; 54:594-606. 3. Malcolm Coppleson, John M. Monagham, C. Paul Morrow: Gynecologic Oncology Epidemiology of cancer, 2 nd vol.i, 1992; 11. 4. T.P. Thamboo, M Salto-Tellez, KB Tan, B Nilson, A Rajwanshi.Cervical cytology: An audit in a Singapore Teaching Hospital. Singapore Med J 2003. 44 (5): 256-260. 5. Mishra S, Srivastava S, Singh U, Srivastava AN. Risk factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian J Cancer 2009; 46:155-9. 6. Shrestha M.M, Pradhan S., Shrestha B. Evaluation of the comparative efficiency of single and double freeze technique of cryotherapy in controlling CIN lesions in Bharatpur Municipality, Chitwan, Nepal a randomized clinical trial. 1 st National oncology conference souvenir, organized by B.P. Koirala Memorial Cancer Hospital. Chitwan, Bharatpur.3-5Dec 2004; page-16. 7. Dawn CS: Cervical intraepithelial neoplasia in text book of Gynecology and contraception.11 th Ed published by Arati Dawn 1992; 395-96. 8. Larry J. Copeland, John F Jarrell. Premalignant lesions of the cervix.text book of Gynecology2 nd Ed.1993, 1226. 9. Bethesda workshop. The Bethesda system for reporting cervical/vaginal diagnosis. Acta.Cytol. 1993:37:115-124. 10. J Monsonego et al.liquid-based cytology for primary cervical cancer screening: a multi-centre study.british Journal of Cancer (2001) 84(3), 360-366. 11. Hendriks Cronje, Groesbeck P.,Parham Bruno F. Cooreman. A comparison of four screening methods for cervical neoplasia in a developing country. American Journal of obstetrics and Gynecology.2003. vol188. No.2:395-400. 12. Sharma Sudha. Down staging of carcinoma cervix: A suitable of approach for low resource settings. J.NP. Med. Assoc. 2000, 39:195-198. 13. Mulay K, Swain M, Patra S,Gowrishankar S. Comparative study of cervical smears in an Urban Hospital in India and population-based screening program in Mauritus. Indian J Pathol Microbol. 2009; 52:34-7. 14. Shrivastav Veena, Bhanot UK. Prospective study of 100 cases of Pap smears. J. NP Med. Assoc. 1998.37: 635-640. International Journal of Health Sciences & Research (www.ijhsr.org) 107

15. Tbistle PJ, Chirenje ZM.Cervical cancer screening in a rural population of Zimbabwe. Cent Afr J Med 1997; 43:246-51. 16. Lorendana M. Alasio, Claudia A, Pierangela G, MarioR, Performance of Autopap primary screening system in the detection of high risk cases in cervicovaginal smears. Acta. Cytology 2001, 1(45).704-708. 17. M.G. Mostafa, Songsee S, Mana R: Accuracy of cytological findings in abnormal cervical smears by cytohistologic comparision. Indian J. of Pathology and Microbiology: 2000; 43: 23-29. 18. Louis Jacques Van Bogaert, Dona C. Knapp.Opportunistic testing for medically underserved women for cervical cancer in South Africa. Acta.cytological, 2001.Vol45, 313-316. 19. Misra S, Srivastav S, Singh U, Srivastav AN.Risk factors and strategies for control of carcinoma cervix in India: Hospital based cytological screening experience of 35 years. Indian J Cancer 2009; 46: 155-9. 20. Patten SF, Lewis GC, Wentz WB, Jaffle RC: Dysplasia of the uterine cervix. New concepts in Gynecology oncology. 1966; 33-34. 21. Reagin JW, Hick D: A study of in situ and squamous cell cancer of the uterine cervix. Cancer. 1953; 6: 1200-1214. 22. J. Kobilkova, B. Pazderink, J. Duskova. Incidence of cervical carcinoma in the Czech Republic Acta. Cytology 2001; 45: 515-518. 23. Ryan KJ, Berkowitz R, Barbieri RL: The cervix in Kistener s Gynecology.5 th Ed.Year book Medical Publishres.1990; 160. 24. La. Veccchia C, Francheschi S, Decarli A, Fasoli H. Gentile A, Parazzini F. Regallo M : Sexual factors, Veneral disease, and risk of intraepithelial and invasive cervical neoplasia. Cancer.1986; 58: 935-41. 25. Herrero R., Brinton LA, Reeves WC, Brenes MM, Tenorio F, Sexual behaviour general disease,hygiene practice and invasive cervical cancer in a high-risk population cancer.1990; 65:380-86. 26. Moghal N. Diagnostic value of endometrial curettage in abnormal uterine bleeding-a histopathological study.j Pak Med Assoc 1997; 47:295-299. 27. Stjernsward J. Plotting a new course for cervical cancer screening in developing countries, World Health Forum. 1987; 8 (1): 42-45. 28. American Cancer Society. Summary of American Cancer Society recommendations for the early detection of cancer in asymptomatic people. CA Cancer J Clin 1993; 43:42-46. How to cite this article: Shrestha S, Pande K. A retrospective analysis of 1000 cases of cervical pap smears. Int J Health Sci Res. 2017; 7(2):103-108. *********** International Journal of Health Sciences & Research (www.ijhsr.org) 108